Development of NP-Based Universal Vaccine for Influenza A Viruses
The nucleoprotein (NP) is a vital target for the heterosubtypic immunity of CD8<sup>+</sup> cytotoxic T lymphocytes (CTLs) due to its conservation among influenza virus subtypes. To further enhance the T cell immunity of NP, autophagy-inducing peptide C5 (AIP-C5) from the CFP10 protein o...
Main Authors: | Ekramy E. Sayedahmed, Nelly O. Elshafie, Andrea P. dos Santos, Chinnaswamy Jagannath, Suryaprakash Sambhara, Suresh K. Mittal |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-02-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/12/2/157 |
Similar Items
-
Adenoviral Vector-Based Vaccine Platforms for Developing the Next Generation of Influenza Vaccines
by: Ekramy E. Sayedahmed, et al.
Published: (2020-10-01) -
Progress towards the Development of a Universal Influenza Vaccine
by: Wen-Chien Wang, et al.
Published: (2022-07-01) -
Vaccine approaches conferring cross-protection against influenza viruses
by: Sai V Vemula, et al.
Published: (2017-11-01) -
Protein transduction domain-mediated influenza NP subunit vaccine generates a potent immune response and protection against influenza virus in mice
by: Yuan Yin, et al.
Published: (2020-01-01) -
Adenoviral Vector-Based Vaccine Expressing Hemagglutinin Stem Region with Autophagy-Inducing Peptide Confers Cross-Protection Against Group 1 and 2 Influenza A Viruses
by: Wen-Chien Wang, et al.
Published: (2025-01-01)